Trial intelligence / Profile preview

KL280006 injection for postoperative analgesia after laparoscopic abdominal surgery

CTR20212404Phase 2Completed

Sponsor
Kelun-Biotech
Start
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of KL280006 in acute postoperative pain, sponsored by Kelun-Biotech. Started Sep 2021; status: completed.

02

Drugs

KL280006
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on CTR20212404.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20212404.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call